208 related articles for article (PubMed ID: 24057429)
1. Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
Thewissen K; Nuyts AH; Deckx N; Van Wijmeersch B; Nagels G; D'hooghe M; Willekens B; Cras P; Eijnde BO; Goossens H; Van Tendeloo VF; Stinissen P; Berneman ZN; Hellings N; Cools N
Mult Scler; 2014 Apr; 20(5):548-57. PubMed ID: 24057429
[TBL] [Abstract][Full Text] [Related]
2. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
[TBL] [Abstract][Full Text] [Related]
3. T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
Ruocco G; Rossi S; Motta C; Macchiarulo G; Barbieri F; De Bardi M; Borsellino G; Finardi A; Grasso MG; Ruggieri S; Gasperini C; Furlan R; Centonze D; Battistini L; Volpe E
Clin Sci (Lond); 2015 Aug; 129(4):291-303. PubMed ID: 25700150
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
Benešová Y; Vašků A; Stourač P; Hladíková M; Fiala A; Bednařík J
J Neuroimmunol; 2013 Feb; 255(1-2):92-6. PubMed ID: 23186557
[TBL] [Abstract][Full Text] [Related]
5. Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.
Stasiolek M; Bayas A; Kruse N; Wieczarkowiecz A; Toyka KV; Gold R; Selmaj K
Brain; 2006 May; 129(Pt 5):1293-305. PubMed ID: 16513684
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response.
Karni A; Abraham M; Monsonego A; Cai G; Freeman GJ; Hafler D; Khoury SJ; Weiner HL
J Immunol; 2006 Sep; 177(6):4196-202. PubMed ID: 16951385
[TBL] [Abstract][Full Text] [Related]
7. Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosis.
Deckx N; Willekens B; Wens I; Eijnde BO; Goossens H; Van Damme P; Berneman ZN; Cools N
Innate Immun; 2016 May; 22(4):266-73. PubMed ID: 27036414
[TBL] [Abstract][Full Text] [Related]
8. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
Cocco E; Sardu C; Murru R; Frau J; Lorefice L; Mamusa E; Contu P; Marrosu MG
Mult Scler; 2009 Sep; 15(9):1030-6. PubMed ID: 19625333
[TBL] [Abstract][Full Text] [Related]
10. Altered maturation of circulating dendritic cells in primary progressive MS patients.
López C; Comabella M; Al-zayat H; Tintoré M; Montalban X
J Neuroimmunol; 2006 Jun; 175(1-2):183-91. PubMed ID: 16698091
[TBL] [Abstract][Full Text] [Related]
11. No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.
Lutterotti A; Jelcić I; Schulze C; Schippling S; Breiden P; Mazzanti B; Reinhardt S; DiGioia M; Repice A; Massacesi L; Sputtek A; Salinas-Riester G; Kroeger N; Sospedra M; Saccardi R; Zander A; Martin R
Mult Scler; 2012 Aug; 18(8):1188-92. PubMed ID: 22252466
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.
Gillett A; Thessen Hedreul M; Khademi M; Espinosa A; Beyeen AD; Jagodic M; Kockum I; Harris RA; Olsson T
Mult Scler; 2010 Sep; 16(9):1056-65. PubMed ID: 20354066
[TBL] [Abstract][Full Text] [Related]
13. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis.
Schwab N; Zozulya AL; Kieseier BC; Toyka KV; Wiendl H
J Immunol; 2010 May; 184(9):5368-74. PubMed ID: 20357264
[TBL] [Abstract][Full Text] [Related]
14. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
Stojković L; Djurić T; Stanković A; Dinčić E; Stančić O; Veljković N; Alavantić D; Zivković M
J Neuroimmunol; 2012 Apr; 245(1-2):87-92. PubMed ID: 22261545
[TBL] [Abstract][Full Text] [Related]
15. Expression Analysis of Long Non-coding RNA Lnc-DC in HLA-DRB1*15:01-Negative Patients with Multiple Sclerosis: A Probable Cause for Gender Differences in Multiple Sclerosis Susceptibility?
Bahrami T; Taheri M; Javadi S; Omrani MD; Karimipour M
J Mol Neurosci; 2021 Apr; 71(4):821-825. PubMed ID: 32951137
[TBL] [Abstract][Full Text] [Related]
16. Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis.
Graves MC; Benton M; Lea RA; Boyle M; Tajouri L; Macartney-Coxson D; Scott RJ; Lechner-Scott J
Mult Scler; 2014 Jul; 20(8):1033-41. PubMed ID: 24336351
[TBL] [Abstract][Full Text] [Related]
17. The role of the Epstein-Barr virus receptor CD21 in multiple sclerosis.
Toepfner N; Cepok S; Grummel V; Hemmer B
J Neuroimmunol; 2012 Jan; 242(1-2):47-51. PubMed ID: 22137275
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D-mediated immune regulation in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
J Neurol Sci; 2011 Dec; 311(1-2):23-31. PubMed ID: 21723567
[TBL] [Abstract][Full Text] [Related]
19. Increased CD8+ central memory T cells in patients with multiple sclerosis.
Liu GZ; Fang LB; Hjelmström P; Gao XG
Mult Scler; 2007 Mar; 13(2):149-55. PubMed ID: 17439879
[TBL] [Abstract][Full Text] [Related]
20. Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.
Corsetti M; Ruocco G; Ruggieri S; Gasperini C; Battistini L; Volpe E
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
